{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:24:03Z","timestamp":1790774643185,"version":"4.1.0"},"reference-count":52,"publisher":"IMR Press","issue":"6","license":[{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Shanghai Municipal Health System Key Discipline (New) Program: \u201c2024 Shanghai Municipal Health System Key Discipline - Orthopedic Surgery\u201d","award":["2024ZDXK0033"],"award-info":[{"award-number":["2024ZDXK0033"]}]},{"name":"Shanghai Science and Technology Innovation Action Plan Natural-Science Foundation Project","award":["23ZR1449800"],"award-info":[{"award-number":["23ZR1449800"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Biosci. (Landmark Ed)"],"abstract":"<jats:p>Background: Current osteoporosis (OP) therapies predominantly suppress osteoclastic bone resorption, highlighting a critical unmet need for anabolic strategies that directly stimulate bone formation. Meteorin-like (Metrnl) is a recently identified adipokine whose role in bone metabolism remains poorly defined and controversial. This study systematically investigated the expression profile, physiological function, and molecular mechanism of Metrnl in skeletal biology. Methods: An integrated approach combining clinical bone marrow specimen analysis, proteomics, single-cell RNA sequencing, and conditional genetic ablation mouse models was utilized. Skeletal phenotypes were evaluated via Micro-CT and bone histomorphometry. Intracellular molecular interactions were determined through co-immunoprecipitation and transcriptional activity assays. Results: Clinically, Metrnl expression was significantly diminished in bone marrow samples from postmenopausal women with OP, suggesting potential relevance to human disease. In mice, Metrnl was predominantly expressed in osteoprogenitor cells, and its expression declined progressively with age. Unexpectedly, systemic knockout (n = 6 per group) of Metrnl resulted in a marked increase in trabecular bone mass (bone volume to total volume ratio [BV\/TV]: 4.11 \u00b1 0.08% vs. 3.89 \u00b1 0.12%, p &lt; 0.01) and bone formation rate (Bone formation rate per bone surface [BFR\/BS]: 0.50 \u00b1 0.03 vs. 0.38 \u00b1 0.03 \u03bcm\/day*100, p &lt; 0.05) without affecting osteoclast activity. This anabolic phenotype was fully recapitulated in osteoblast-specific (Ocn-Cre) and osteoprogenitor-specific (Prx1-Cre) conditional knockout mice (n = 6 per group), which both exhibited significantly higher BV\/TV (4.13 \u00b1 0.06% and 4.04 \u00b1 0.05%, respectively) compared to controls (3.88 \u00b1 0.08%; p &lt; 0.001 and p &lt; 0.01, respectively), establishing a cell-autonomous inhibitory role of Metrnl in osteogenesis. Mechanistically, intracellular Metrnl directly interacts with the scaffold protein Receptor for activated C kinase 1 (Rack1), thereby disrupting the PKC-\u03b1\u2013Rack1 complex, reducing Brain and Muscle ARNT-Like 1 (Bmal1) phosphorylation, and facilitating its nuclear translocation. This process subsequently upregulates transcription of the circadian clock gene Cryptochrome 2 (Cry2), thereby suppressing osteoblast differentiation. Conclusions: Collectively, these findings identify Metrnl as a previously unrecognized negative regulator of bone formation and uncover a Rack1-PKC\u03b1-Bmal1-Cry2 signaling axis that links circadian regulation to osteogenesis. These results establish a conceptual framework for targeting Metrnl-mediated pathways in the development of anabolic therapies for OP.<\/jats:p>","DOI":"10.31083\/fbl53692","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T10:50:51Z","timestamp":1783421451000},"source":"Crossref","is-referenced-by-count":1,"title":["An Integrated Approach Reveals the Pre-Osteoblast-Driven Metrnl Synergizes With Circadian Genes to Inhibit Osteogenesis"],"prefix":"10.31083","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-3052-7937","authenticated-orcid":true,"given":"Wenchao","family":"Fei","sequence":"first","affiliation":[{"name":"Department of Orthopedics, The Fifth People\u2019s Hospital of Shanghai, Fudan University, 200040 Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6163-5899","authenticated-orcid":true,"given":"Ke","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, The Fifth People\u2019s Hospital of Shanghai, Fudan University, 200040 Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MingMing","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, The Fifth People\u2019s Hospital of Shanghai, Fudan University, 200040 Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyi","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, The Fifth People\u2019s Hospital of Shanghai, Fudan University, 200040 Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, The Fifth People\u2019s Hospital of Shanghai, Fudan University, 200040 Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conghui","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, The Fifth People\u2019s Hospital of Shanghai, Fudan University, 200040 Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqing","family":"Tong","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, The Fifth People\u2019s Hospital of Shanghai, Fudan University, 200040 Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zelin","family":"Yue","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, The Fifth People\u2019s Hospital of Shanghai, Fudan University, 200040 Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2058-1191","authenticated-orcid":true,"given":"Yinghua","family":"Li","sequence":"additional","affiliation":[{"name":"Central Laboratory, The Fifth People's Hospital of Shanghai, Fudan University, 200040 Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8010-400X","authenticated-orcid":true,"given":"Yang","family":"Hong","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, The Fifth People\u2019s Hospital of Shanghai, Fudan University, 200040 Shanghai, China"},{"name":"Shanghai Clinical Research Center for Aging and Medicine, 200040 Shanghai, China"},{"name":"Center of Community-Based Health Research, Fudan University, 200040 Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16242","published-online":{"date-parts":[[2026,6,24]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Ye C, Ebeling P, Kline G. Osteoporosis. Lancet (London, England). 2025; 406: 2003\u20132016.","DOI":"10.1016\/S0140-6736(25)01385-6"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Leder BZ, Tsai JN, Uihlein AV, Wallace PM, Lee H, Neer RM, et al. Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial. Lancet (London, England). 2015; 386: 1147\u20131155.","DOI":"10.1016\/S0140-6736(15)61120-5"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Karsenty G, Khosla S. The crosstalk between bone remodeling and energy metabolism: A translational perspective. Cell Metabolism. 2022; 34: 805\u2013817.","DOI":"10.1016\/j.cmet.2022.04.010"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Reid IR, Billington EO. Drug therapy for osteoporosis in older adults. Lancet (London, England). 2022; 399: 1080\u20131092.","DOI":"10.1016\/S0140-6736(21)02646-5"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Yu W, Zhong L, Yao L, Wei Y, Gui T, Li Z, et al. Bone marrow adipogenic lineage precursors promote osteoclastogenesis in bone remodeling and pathologic bone loss. The Journal of Clinical Investigation. 2021; 131: e140214.","DOI":"10.1172\/JCI140214"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Chang LL, Eastell R, Miller PD. Continuation of Bisphosphonate Therapy for Osteoporosis beyond 5 Years. The New England Journal of Medicine. 2022; 386: 1467\u20131469.","DOI":"10.1056\/NEJMclde2115900"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Ma S, Goh EL, Jin A, Bhattacharya R, Boughton OR, Patel B, et al. Long-term effects of bisphosphonate therapy: perforations, microcracks and mechanical properties. Scientific Reports. 2017; 7: 43399.","DOI":"10.1038\/srep43399"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Billington E, Aghajafari F, Skulsky E, Kline GA. Bisphosphonates. BMJ (Clinical Research Ed.). 2024; 386: e076898.","DOI":"10.1136\/bmj-2023-076898"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Mizoguchi T, Ono N. The diverse origin of bone-forming osteoblasts. Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research. 2021; 36: 1432\u20131447.","DOI":"10.1002\/jbmr.4410"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Amarasekara DS, Kim S, Rho J. Regulation of Osteoblast Differentiation by Cytokine Networks. International Journal of Molecular Sciences. 2021; 22: 2851.","DOI":"10.3390\/ijms22062851"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Dalle Carbonare L, Bertacco J, Marchetto G, Cheri S, Deiana M, Minoia A, et al. Methylsulfonylmethane enhances MSC chondrogenic commitment and promotes pre-osteoblasts formation. Stem Cell Research & Therapy. 2021; 12: 326.","DOI":"10.1186\/s13287-021-02396-5"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Chen E, Liu G, Zhou X, Zhang W, Wang C, Hu D, et al. Concentration-dependent, dual roles of IL-10 in the osteogenesis of human BMSCs via P38\/MAPK and NF-\u03baB signaling pathways. FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology. 2018; 32: 4917\u20134929.","DOI":"10.1096\/fj.201701256RRR"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Han Y, Gao H, Gan X, Liu J, Bao C, He C. Roles of IL-11 in the regulation of bone metabolism. Frontiers in Endocrinology. 2023; 14: 1290130.","DOI":"10.3389\/fendo.2023.1290130"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Li S, Liu G, Hu S. Osteoporosis: interferon-gamma-mediated bone remodeling in osteoimmunology. Frontiers in Immunology. 2024; 15: 1396122.","DOI":"10.3389\/fimmu.2024.1396122"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Kim BJ, Koh JM. Coupling factors involved in preserving bone balance. Cellular and Molecular Life Sciences : CMLS. 2019; 76: 1243\u20131253.","DOI":"10.1007\/s00018-018-2981-y"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Sims NA, L\u00e9vesque JP. Oncostatin M: Dual Regulator of the Skeletal and Hematopoietic Systems. Current Osteoporosis Reports. 2024; 22: 80\u201395.","DOI":"10.1007\/s11914-023-00837-z"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Yao Q, He L, Bao C, Yan X, Ao J. The role of TNF-\u03b1 in osteoporosis, bone repair and inflammatory bone diseases: A review. Tissue and Cell. 2024; 89: 102422.","DOI":"10.1016\/j.tice.2024.102422"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Constanze B, Popper B, Aggarwal BB, Shakibaei M. Evidence that TNF-\u03b2 suppresses osteoblast differentiation of mesenchymal stem cells and resveratrol reverses it through modulation of NF-\u03baB, Sirt1 and Runx2. Cell and Tissue Research. 2020; 381: 83\u201398.","DOI":"10.1007\/s00441-020-03188-8"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Ura K, Morimoto I, Watanabe K, Saito K, Yanagihara N, Eto S. Interleukin (IL)-4 and IL-13 inhibit the differentiation of murine osteoblastic MC3T3-E1 cells. Endocrine Journal. 2000; 47: 293\u2013302.","DOI":"10.1507\/endocrj.47.293"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Razawy W, Alves CH, Koedam M, Asmawidjaja PS, Mus AMC, Oukka M, et al. IL-23 receptor deficiency results in lower bone mass via indirect regulation of bone formation. Scientific Reports. 2021; 11: 10244.","DOI":"10.1038\/s41598-021-89625-2"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Loh HY, Norman BP, Lai KS, Cheng WH, Nik Abd Rahman NMA, Mohamed Alitheen NB, et al. Post-Transcriptional Regulatory Crosstalk between MicroRNAs and Canonical TGF-\u03b2\/BMP Signalling Cascades on Osteoblast Lineage: A Comprehensive Review. International Journal of Molecular Sciences. 2023; 24: 6423.","DOI":"10.3390\/ijms24076423"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Wu M, Wu S, Chen W, Li YP. The roles and regulatory mechanisms of TGF-\u03b2 and BMP signaling in bone and cartilage development, homeostasis and disease. Cell Research. 2024; 34: 101\u2013123.","DOI":"10.1038\/s41422-023-00918-9"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Li ZY, Zheng SL, Wang P, Xu TY, Guan YF, Zhang YJ, et al. Subfatin is a novel adipokine and unlike Meteorin in adipose and brain expression. CNS Neuroscience & Therapeutics. 2014; 20: 344\u2013354.","DOI":"10.1111\/cns.12219"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"J\u00f8rgensen JR, Fransson A, Fjord-Larsen L, Thompson LH, Houchins JP, Andrade N, et al. Cometin is a novel neurotrophic factor that promotes neurite outgrowth and neuroblast migration in vitro and supports survival of spiral ganglion neurons in vivo. Experimental Neurology. 2012; 233: 172\u2013181.","DOI":"10.1016\/j.expneurol.2011.09.027"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Li ZY, Fan MB, Zhang SL, Qu Y, Zheng SL, Song J, et al. Intestinal Metrnl released into the gut lumen acts as a local regulator for gut antimicrobial peptides. Acta Pharmacologica Sinica. 2016; 37: 1458\u20131466.","DOI":"10.1038\/aps.2016.70"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Bridgewood C, Russell T, Weedon H, Baboolal T, Watad A, Sharif K, et al. The novel cytokine Metrnl\/IL-41 is elevated in Psoriatic Arthritis synovium and inducible from both entheseal and synovial fibroblasts. Clinical Immunology (Orlando, Fla.). 2019; 208: 108253.","DOI":"10.1016\/j.clim.2019.108253"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Miao ZW, Chen J, Chen CX, Zheng SL, Zhao HY, Miao CY. Metrnl as a secreted protein: Discovery and cardiovascular research. Pharmacology & Therapeutics. 2024; 263: 108730.","DOI":"10.1016\/j.pharmthera.2024.108730"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Zheng SL, Li ZY, Song J, Liu JM, Miao CY. Metrnl: a secreted protein with new emerging functions. Acta Pharmacologica Sinica. 2016; 37: 571\u2013579.","DOI":"10.1038\/aps.2016.9"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Li ZY, Song J, Zheng SL, Fan MB, Guan YF, Qu Y, et al. Adipocyte Metrnl Antagonizes Insulin Resistance Through PPAR\u03b3 Signaling. Diabetes. 2015; 64: 4011\u20134022.","DOI":"10.2337\/db15-0274"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Lee JO, Byun WS, Kang MJ, Han JA, Moon J, Shin MJ, et al. The myokine meteorin-like (metrnl) improves glucose tolerance in both skeletal muscle cells and mice by targeting AMPK\u03b12. The FEBS Journal. 2020; 287: 2087\u20132104.","DOI":"10.1111\/febs.15301"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Reboll MR, Klede S, Taft MH, Cai CL, Field LJ, Lavine KJ, et al. Meteorin-like promotes heart repair through endothelial KIT receptor tyrosine kinase. Science (New York, N.Y.). 2022; 376: 1343\u20131347.","DOI":"10.1126\/science.abn3027"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Gong W, Liu Y, Wu Z, Wang S, Qiu G, Lin S. Meteorin-Like Shows Unique Expression Pattern in Bone and Its Overexpression Inhibits Osteoblast Differentiation. PloS One. 2016; 11: e0164446.","DOI":"10.1371\/journal.pone.0164446"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"Invernizzi M, de Sire A, Carda S, Venetis K, Ren\u00f2 F, Cisari C, et al. Bone Muscle Crosstalk in Spinal Cord Injuries: Pathophysiology and Implications for Patients' Quality of Life. Current Osteoporosis Reports. 2020; 18: 422\u2013431.","DOI":"10.1007\/s11914-020-00601-7"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"Gonzalez-Gil AM, Elizondo-Montemayor L. The Role of Exercise in the Interplay between Myokines, Hepatokines, Osteokines, Adipokines, and Modulation of Inflammation for Energy Substrate Redistribution and Fat Mass Loss: A Review. Nutrients. 2020; 12: 1899.","DOI":"10.3390\/nu12061899"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"Huang R, Balu AR, Molitoris KH, White JP, Robling AG, Ayturk UM, et al. The role of Meteorin-like in skeletal development and bone fracture healing. Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society. 2022; 40: 2510\u20132521.","DOI":"10.1002\/jor.25286"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"Steinberg SF. Structural basis of protein kinase C isoform function. Physiological Reviews. 2008; 88: 1341\u20131378.","DOI":"10.1152\/physrev.00034.2007"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"Battaini F, Pascale A. Protein kinase C signal transduction regulation in physiological and pathological aging. Annals of the New York Academy of Sciences. 2005; 1057: 177\u2013192.","DOI":"10.1196\/annals.1356.011"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"Racaud-Sultan C, Vergnolle N. GSK3\u03b2, a Master Kinase in the Regulation of Adult Stem Cell Behavior. Cells. 2021; 10: 225.","DOI":"10.3390\/cells10020225"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"Robles MS, Boyault C, Knutti D, Padmanabhan K, Weitz CJ. Identification of RACK1 and protein kinase Calpha as integral components of the mammalian circadian clock. Science (New York, N.Y.). 2010; 327: 463\u2013466.","DOI":"10.1126\/science.1180067"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"Tang Z, Xu T, Li Y, Fei W, Yang G, Hong Y. Inhibition of CRY2 by STAT3\/miRNA-7-5p Promotes Osteoblast Differentiation through Upregulation of CLOCK\/BMAL1\/P300 Expression. Molecular Therapy. Nucleic Acids. 2020; 19: 865\u2013876.","DOI":"10.1016\/j.omtn.2019.12.020"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"Tsang K, Liu H, Yang Y, Charles JF, Ermann J. Defective circadian control in mesenchymal cells reduces adult bone mass in mice by promoting osteoclast function. Bone. 2019; 121: 172\u2013180.","DOI":"10.1016\/j.bone.2019.01.016"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"Maronde E, Schilling AF, Seitz S, Schinke T, Schmutz I, van der Horst G, et al. The clock genes Period 2 and Cryptochrome 2 differentially balance bone formation. PloS One. 2010; 5: e11527.","DOI":"10.1371\/journal.pone.0011527"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"Marini F, Giusti F, Palmini G, Brandi ML. Role of Wnt signaling and sclerostin in bone and as therapeutic targets in skeletal disorders. Osteoporosis International : a Journal Established as Result of Cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2023; 34: 213\u2013238.","DOI":"10.1007\/s00198-022-06523-7"},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"Kocijan R, Muschitz C, Fahrleitner-Pammer A, Amrein K, Pietschmann P, Haschka J, et al. Serum sclerostin levels are decreased in adult patients with different types of osteogenesis imperfecta. The Journal of Clinical Endocrinology and Metabolism. 2014; 99: E311\u20139.","DOI":"10.1210\/jc.2013-2244"},{"key":"ref45","doi-asserted-by":"publisher","unstructured":"Reppe S, Noer A, Grimholt RM, Halld\u00f3rsson BV, Medina-Gomez C, Gautvik VT, et al. Methylation of bone SOST, its mRNA, and serum sclerostin levels correlate strongly with fracture risk in postmenopausal women. Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research. 2015; 30: 249\u2013256.","DOI":"10.1002\/jbmr.2342"},{"key":"ref46","doi-asserted-by":"publisher","unstructured":"Li J, Ye P, Si J, Xiang G. Meteorin-like\/Metrnl: A pleiotropic cytokine implicated in metabolic, inflammatory and malignant disorders. Cytokine & Growth Factor Reviews. 2026; 87: 64\u201372.","DOI":"10.1016\/j.cytogfr.2025.12.003"},{"key":"ref47","doi-asserted-by":"publisher","unstructured":"Tamaru T, Hattori M, Honda K, Nakahata Y, Sassone-Corsi P, van der Horst GTJ, et al. CRY Drives Cyclic CK2-Mediated BMAL1 Phosphorylation to Control the Mammalian Circadian Clock. PLoS Biology. 2015; 13: e1002293.","DOI":"10.1371\/journal.pbio.1002293"},{"key":"ref48","doi-asserted-by":"publisher","unstructured":"Yuan VG. Rhythms in Remodeling: Posttranslational Regulation of Bone by the Circadian Clock. Biomedicines. 2025; 13: 705.","DOI":"10.3390\/biomedicines13030705"},{"key":"ref49","doi-asserted-by":"publisher","unstructured":"Qin Y, Chen ZH, Wu JJ, Zhang ZY, Yuan ZD, Guo DY, et al. Circadian clock genes as promising therapeutic targets for bone loss. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 2023; 157: 114019.","DOI":"10.1016\/j.biopha.2022.114019"},{"key":"ref50","doi-asserted-by":"publisher","unstructured":"Luo B, Zhou X, Tang Q, Yin Y, Feng G, Li S, et al. Circadian rhythms affect bone reconstruction by regulating bone energy metabolism. Journal of Translational Medicine. 2021; 19: 410.","DOI":"10.1186\/s12967-021-03068-x"},{"key":"ref51","doi-asserted-by":"publisher","unstructured":"Ze Y, Wu Y, Tan Z, Li R, Li R, Gao W, et al. Signaling pathway mechanisms of circadian clock gene Bmal1 regulating bone and cartilage metabolism: a review. Bone Research. 2025; 13: 19.","DOI":"10.1038\/s41413-025-00403-6"},{"key":"ref52","doi-asserted-by":"publisher","unstructured":"Yu S, Tang Q, Chen G, Lu X, Yin Y, Xie M, et al. Circadian rhythm modulates endochondral bone formation via MTR1\/AMPK\u03b21\/BMAL1 signaling axis. Cell Death and Differentiation. 2022; 29: 874\u2013887.","DOI":"10.1038\/s41418-021-00919-4"}],"container-title":["Frontiers in Bioscience-Landmark"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/31\/6\/10.31083\/FBL53692","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T10:52:48Z","timestamp":1783421568000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/31\/6\/10.31083\/FBL53692"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,24]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026]]}},"alternative-id":["S2768-6701(26)02149-0"],"URL":"https:\/\/doi.org\/10.31083\/fbl53692","relation":{},"ISSN":["2768-6701","2768-6698"],"issn-type":[{"value":"2768-6701","type":"print"},{"value":"2768-6698","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,24]]},"article-number":"53692"}}